Regulation of Iodothyronine 5′-Deiodinases: Effects of Thiol Blockers and Altered Substrate Levelsin Vivoandin Vitro
- 1 May 1990
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 126 (5), 2597-2606
- https://doi.org/10.1210/endo-126-5-2597
Abstract
To study the physiological regulation of the iodothyronine 5''-deiodinases (I-5''D), we have examined the effects of some thiol blockers and of thyroid status on I-5''D activities both in vitro and in vivo. At low (<5 mM) concentrations of dithiothreitol, propylthiouracil (PTU) inhibited I-5''D in the brain, pituitary, and brown adipose tissue (BAT) of hypothyroid rats (which contain predominantly the type II activity); the patterns of inhibition in these tissues were essentially similar, with a Ki of about 175 .mu.M at 250 .mu.M dithiothreitol. Hydroxyethyldisulfide was a strong inhibitor of the type II enzyme, with relatively little effect on the renal enzyme at both high concentrations (micromolar) of T4, i.e. predominantly type I activity, and low concentrations (nanomolar) to T4, i.e. both type I and low Km activity. Preincubation of cerebral microsomes with PTU, followed by removal of excess PTU, resulted in 70% inhibition of I-5''D activity in cerebral microsomes at 5 mM dithiothreitol; the corresponding inhibitions of the renal enzyme at high and low substrate concentrations were 66% and 48%, respectively. Specific binding of PTU to renal and cerebral microsomes was diminished by hydroxyethyldisulfide, but not by T4, suggesting that PTU binding was not dependent on substrate interaction. Administration of PTU in vivo (1 mg/100 g BW, ip; 1 h before killing) resulted in approximately 80% inhibition of I-5''D activity in renal microsomes at high T4, and 50-70% inhibition in pituitary, BAT, and renal microsomes at low T4, but no inhibition was observed in brain microsomes. HPLC analyses revealed a PTU content of 35-65 nmol/g wet wt in the pituitary, BAT, liver, and kidney, but no PTU was detected in the brain, suggesting that PTU may be excluded by the blood-brain barrier. Maintaining hypothyroid rats on 1 .mu.g T4/100 g BW .cntdot. day for 5 days enhanced renal type I and low Km I-5''D with restoration of serum T3 to normal levels, although the type II I-5''Ds from all sources were severely depressed. A supraphysiological dose of T4 depressed all three I-5''Ds. The data indicate that the I-5''Ds are regulated in a qualitatively similar fashion.This publication has 23 references indexed in Scilit:
- Evidence for Two Pathways of Iodothyronine 5′-Deiodination in Rat Pituitary That Differ in Kinetics, Propylthiouracil Sensitivity, and Response to HypothyroidismJournal of Clinical Investigation, 1983
- Comparison of Iodothyronine 5′-Deiodinase and Other Thyroid-Hormone-dependent Enzyme Activities in the Cerebral Cortex of Hypothyroid Neonatal RatJournal of Clinical Investigation, 1982
- Evidence for Two Tissue-specific Pathways for In Vivo Thyroxine 5′-Deiodination in the RatJournal of Clinical Investigation, 1982
- Effect of Alterations in Thyroid Status on the Metabolism of Thyroxine and Triiodothyronine by Rat Pituitary Gland In VitroJournal of Clinical Investigation, 1982
- Cerebral Cortex Responds Rapidly to Thyroid HormonesScience, 1981
- Changes in the Particulate Subcellular Component of Hepatic Thyroxine-5&-Monodeiodinase in Hyperthyroid and Hypothyroid Rats*Endocrinology, 1979
- Inhibition of intrapituitary thyroxine to 3.5.3'-triiodothyronine conversion prevents the acute suppression of thyrotropin release by thyroxine in hypothyroid rats.Journal of Clinical Investigation, 1979
- Thyroxine 5′-Deiodinase Activity of Rat Kidney: Observations on Activation by Thiols and Inhibition by Propylthiouracil*Endocrinology, 1978
- Iodothyronine Metabolism in Rat Liver HomogenatesJournal of Clinical Investigation, 1978
- A Study of Extrathyroidal Conversion of Thyroxine (T4) to 3,3′,5-Triiodothyronine (T3) in Vitro*Endocrinology, 1977